Regulatory Strategy: Top 5 Mistakes Healthtech Founders Make | Dose 060
Dreamit Dreamit
27.5K subscribers
1,851 views
0

 Published On Jan 27, 2022

Pitching your regulatory strategy to investors? Avoid these 5 common mistakes.
Book office hours with Dreamit Ventures ► https://www.dreamit.com/office-hours
Tell us more about your startup ► https://www.dreamit.com/tell-us-more
Blog on FDA’s view of company promotion ► https://bit.ly/3KRWMKL

Relative to other industries, healthcare innovation certainly has some barriers to entry. Researching regulatory requirements for healthcare startups? How do you create a regulatory strategy? The answer is always situational with varying approaches to regulatory strategy for medical device start-ups, regulatory strategy for SaMD startups, or regulatory strategy for digital health startups more broadly. Words matter and a seasoned health investor can easily pick apart a shotty regulatory strategy. In this Dose, Adam Dakin, Partner for Dreamit Healthtech, reveals 5 common mistakes health founders make when pitching their regulatory strategy to VCs. Related to this topic are use cases like explaining your research to investors, pitching clinical data to VCs, and how generally how to pitch clinical data. Get 5 key steps to regulatory strategy presentation in this 8-minute Dreamit Dose!

0:00 - Intro
0:38 - Basics on Regulatory Strategy
1:39 - #1 | Cleared or Approval?
2:42 - #2 | The Knee Jerk Reaction
3:52 - #3 | A Cavalier Attitude
4:47 - #4 | No Regulatory Strategy
5:23 - #5 | GTM Misalignment
6:41 - Takeaways
7:53 - Outro

show more

Share/Embed